DTC
DCPH

Deep Track Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Deep Track Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,363,201
Closed -$21.1M – 64
2023
Q1 		$21.1M Buy
+1,363,201
New +$22.8M 0.87% 35

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deep Track Capital's DCPH Position: Q2 2023 in Review

Deep Track Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2023, closing a stake of 1,363,201 shares — an estimated $21.1M sold.

Deep Track Capital first reported a position in DCPH in Q1 2023 and held it in 1 quarter. The position peaked at $21.1M in Q1 2023. 145 funds tracked by Wall St. Rank hold DCPH as of Q2 2023.

  • Deep Track Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Deep Track Capital sold 1,363,201 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $21.1M.
  • Deep Track Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Deep Track Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $21.1M in Q1 2023.
  • 145 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Deep Track Capital's 13F filing for Q2 2023, filed 14 Aug 2023.